Stocks股票 / Health Care / ENOV
ENOV US listed · USD美股 · 美元
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995.易诺维公司(Enovis Corporation)是一家专注于骨科的医疗技术公司。该公司由米切尔·雷尔斯和史蒂文·雷尔斯兄弟于1995年以科尔法克斯公司(Colfax Corporation)之名创立。
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-08-14Earnings财务业绩
Estimates being raised — 1 analysts预期上调 — 1 位分析师
Beat expectations 4 quarters in a row连续 4 季度超预期
Post-earnings drift: -10.1% (20d)财报后漂移:-10.1%(20日)
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度(近几个季度) · average平均 11.1%
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | ENOV | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 0.99x | 3.54 | |
| P/S市销率 | 0.65x | 3.20 | |
| Earnings yield盈利收益率 | -80.70% | 2.51 | |
| FCF yield自由现金流收益率 | 1.36% | 4.00 | |
| Shareholder yield股东收益率 | 0.24% | 1.83 | |
| EV/EBITDA企业价值/EBITDA | 12.41x | 19.05 | |
| P/FCF市值/自由现金流 | 73.69x | 22.49 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: +$0.2M net (1 buyers, 0 sellers)+$0.2M 净值(1 买家,0 卖家)
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Dorsey Asset Management | B | exitexit | 0.0% | 2026-03-31 |
Signal history信号历史
engine events引擎事件Company profile公司档案
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995.易诺维公司(Enovis Corporation)是一家专注于骨科的医疗技术公司。该公司由米切尔·雷尔斯和史蒂文·雷尔斯兄弟于1995年以科尔法克斯公司(Colfax Corporation)之名创立。
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 1.0× | 3.5× | 97% |
| Price / Sales市销率 | 0.7× | 3.2× | 88% |
| EV / EBITDAEV/EBITDA | 12.4× | 19.1× | 82% |
| Earnings yield盈利收益率 | -80.7% | 2.5% | 2% |
| Free-cash-flow yield自由现金流收益率 | 14.8% | 5.3% | 93% |
| Shareholder yield股东综合回报率 | 0.2% | 1.8% | 17% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -2.5% | +1.2% |
| 1 Month近1月 | +4.1% | +3.5% |
| 3 Months近3月 | +5.6% | +5.2% |
| 6 Months近6月 | +17.9% | +14.4% |
| Year to date年初至今 | -3.2% | +14.2% |
| 1 Year近1年 | -13.3% | +21.6% |
| 3 Years近3年 | -54.6% | +79.7% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $3.1B | $3.9B | $1.6B | $1.7B | $2.1B | $2.2B |
| EPS每股收益 | $0.31 | $0.46 | $-0.25 | $-0.61 | $-14.93 | $-20.75 |
| Free cash flow自由现金流 | $187M | $252M | $-161M | $13M | $-67M | $20M |
| Gross margin毛利率 | 41.9% | 41.9% | 55.6% | 58.0% | 56.0% | 59.8% |
| Net margin净利率 | 1.4% | 1.9% | -0.9% | -1.9% | -39.2% | -52.7% |
| FCF margin自由现金流利润率 | 6.1% | 6.5% | -10.3% | 0.7% | -3.2% | 0.9% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: inventory +3% vs sales +-27% — inventory building, demand risk营运资本:存货 +3% 对销售 +-27%——存货积压,需求风险
- Pricing power: gross margin +17.9pts over 6 years定价能力:毛利率 6 年上升 17.9 个百分点
- Capital discipline: investment near the peer median资本纪律:投资力度接近同业中位
- Balance sheet: Altman Z -0.35 — distress zone资产负债表:Altman Z -0.35——困境区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Mar 2026 | $0.89 | $0.82 | +8.5% |
| Dec 2025 | $0.95 | $0.81 | +17.3% |
| Sep 2025 | $0.75 | $0.67 | +11.9% |
| Jun 2025 | $0.79 | $0.74 | +6.8% |
Estimate revisions预期修正
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Dorsey Asset Management | B | Exited清仓 | 0.0% | $61M |
Fund positioning基金持仓概览
Insiders & shorts内部人与空头
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 67% | +4.9% | 3 |
| Feb2月 | 67% | +2.2% | 3 |
| Mar3月 | 33% | -0.4% | 3 |
| Apr4月 | 33% | -8.2% | 3 |
| May5月 | 0% | -8.7% | 3 |
| Jun6月 | 33% | -7.6% | 3 |
| Jul7月 | 50% | +5.6% | 4 |
| Aug8月 | 25% | -1.2% | 4 |
| Sep9月 | 0% | -5.8% | 3 |
| Oct10月 | 33% | -3.7% | 3 |
| Nov11月 | 67% | +7.8% | 3 |
| Dec12月 | 33% | -10.4% | 3 |